by Richard Gliklich, MD, CEO of OM1 and Michelle Leavy, MPH, Head of Health Policy at OM1 Interest in real-world data (RWD) and real-world evidence (RWE) has increased rapidly since the passage of the 21st Century Cures Act in late …
Keep ReadingRWD for Evaluating Device & Diagnostic Performance & Outcomes
By Susan Garfield, Principal at EY Due to COVID-19, stakeholders across the health care and life sciences industry are accelerating their transformation agenda to embrace innovation and leverage digital solutions to drive outcomes. EY spoke with stakeholders across the health …
Keep ReadingHow Medtech and Digital Therapeutics Are Changing the Outcomes Power Paradigm
By The UK’s Department for International Trade “In normal times, innovation is a very slow and ponderous process, and it is particularly slow in healthcare.” — NHS Chair, Lord Prior, speaking at The Virtual MedTech Conference this week As we …
By Peter Shen, Global Head of Research & Development, Medical Devices, Johnson & Johnson While it’s true that COVID-19, along with recent natural disasters, have disrupted how many of us live and work, the need for solutions to the significant …
Keep ReadingInnovation must continue during the time of COVID-19
By Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices Living through a pandemic has put the importance of staying healthy front and center. Health matters. And while many of us are concerned about our health now more than ever …
Keep ReadingPeople Are Worried About Their Health, But They’re Not Going to the Doctor
By Brian Chapman, Principal and Leader of ZS’s Medtech PracticeBrian Chapman is a principal in ZS’s Evanston office and leads ZS’s medtech practice. Brian’s global experience covers the U.S., Europe and Asia. Brian has worked with companies on a range …
Keep ReadingThe medtech mulligan: Why COVID-19 is a reinvention opportunity
by The Coolest Hotspot, Quebec Life Sciences and Health Tech Hub The Quebec medical technology industry has been working around the clock to ramp up production, develop new innovative solutions, and collaborate with our government and health system partners to …
Keep ReadingZooming in on Quebec’s thriving MedTech industry
By Jim Welch, EY Global MedTech Leader, Health Sciences and Wellness In 2019, the medtech industry earned one more year of growth (6.3%), in line with the rate from the year before. But if 2019 seemed like a continuation of …
Keep ReadingCOVID-19 can upend the medtech sector — and even strengthen it
By Jim Welch, EY Global MedTech Leader, Health Sciences and Wellness On August 4, 2020, AdvaMed and EY hosted the first in a series of MedTech CEO roundtables bringing together senior leaders, many of whom are part of AdvaMed’s Accel …
by Gerry Bannister, FNP, Senior Advisor, IDNs, InterSystems Most MedTech companies are looking for the best approach to access, manage and leverage data – in an environment of ever-increasing data volume and complexity. What if you have a great idea …
